Key result
Treatment of severe complicated hypertension resulted in an overall survival of 60% at 5 years, 43% at 10 years, and 21% at 15 years.
Why the study?
Does antihypertensive treatment improve long-term survival in patients with severe complicated hypertension?
Cohort (n=191)
Does antihypertensive treatment improve long-term survival in patients with severe complicated hypertension?
Long-term follow-up of treated severe hypertension shows significant early mortality from renal and cerebral causes, and later mortality from myocardial infarction, highlighting the need for early treatment.
Answers are grounded in this paper and cite their sources.
Poor long-term survival persists after treatment of severe complicated hypertension; leaves open whether earlier intervention improves outcomes.
A follow-up study has been carried out on 191 patients with severe complicated hypertension admitted to a clinic commenced in 1951, and reviewed up to December, 1969. Most patients achieved good or fair blood pressure control and symptomatic state and approximately 80% remained in full work. There was an overall survival of 60% at 5 years, 43% at 10 years and 21% at 15 years. Factors Influencing survival included height of blood pressure (systolic level more significant than diastolic), sex (better for females), age (better for younger patients) and degree of involvement of ocular fundi, heart and kidneys. Eighty-six patients died, the commonest causes of death being cerebral vascular accident (21), myocardial infarction (24) and renal failure (21). Most of the deaths from cerebral and renal causes occurred in the first 5 years of treatment, most of the deaths from myocardial infarction after 5 years. These results are in accord with others in indicating a beneficial effect of treatment in severe hypertension. However, comparison of survival curves with those of the general population leaves no cause for complacency. The need for early treatment of hypertension and elimination of other causes of arterial disease is stressed.
No takes yet. Share an insight, caveat, or question.
Barnett et al. (1973) conducted a cohort in Severe complicated hypertension (n=191). Treatment of severe hypertension vs. General population was evaluated on Overall survival. Treatment of severe complicated hypertension resulted in an overall survival of 60% at 5 years, 43% at 10 years, and 21% at 15 years.
Synapse has enriched 10 related papers. Consider them for comparative context: